RELIEF THERAPEUTICS Holding SA Stock CINNOBER BOAT
Equities
0QKQ
CH0100191136
Biotechnology & Medical Research
Sales 2022 | 6.08M 6.69M 9.1M | Sales 2023 | 6.03M 6.63M 9.03M | Capitalization | 24.96M 27.44M 37.34M |
---|---|---|---|---|---|
Net income 2022 | -50M -54.98M -74.81M | Net income 2023 | -98M -108M -147M | EV / Sales 2022 | 19.3 x |
Net cash position 2022 | 14.89M 16.38M 22.28M | Net cash position 2023 | 10.25M 11.28M 15.34M | EV / Sales 2023 | 2.44 x |
P/E ratio 2022 |
-2.5
x | P/E ratio 2023 |
-0.24
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.87% |
Managers | Title | Age | Since |
---|---|---|---|
Michelle Lock
CEO | Chief Executive Officer | 55 | 22-01-27 |
Ram Selvaraju
CHM | Chairman | 45 | 16-05-24 |
Anthony M. Kim
PRN | Corporate Officer/Principal | - | 21-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ram Selvaraju
CHM | Chairman | 45 | 16-05-24 |
Paolo Galfetti
PRN | Corporate Officer/Principal | 59 | 21-05-26 |
Michelle Lock
CEO | Chief Executive Officer | 55 | 22-01-27 |
1st Jan change | Capi. | |
---|---|---|
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |